Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Hydrocortisone valerate
Drug ID BADD_D01092
Description Not Available
Indications and Usage For the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. Also used to treat endocrine (hormonal) disorders (adrenal insufficiency, Addisons disease). It is also used to treat many immune and allergic disorders, such as arthritis, lupus, severe psoriasis, severe asthma, ulcerative colitis, and Crohn's disease.
Marketing Status Prescription; Discontinued
ATC Code A01AC03; A07EA02; C05AA01; D07AA02; D07XA01; H02AB09; S01BA02; S01CB03; S02BA01
DrugBank ID DB14544
KEGG ID D02288
MeSH ID C038363
PubChem ID 5282494
TTD Drug ID Not Available
NDC Product Code 46204-0689; 68462-836; 0713-0560; 52128-136; 59929-456; 68180-954; 61919-010; 51672-1290; 0713-0668; 68462-575; 0713-0669; 0713-0720; 64958-0080; 45802-455; 51672-1292; 82298-116; 82298-115
Synonyms hydrocortisone valerate | Westcort
Chemical Information
Molecular Formula C26H38O6
CAS Registry Number 57524-89-7
SMILES CCCCC(=O)OC1(CCC2C1(CC(C3C2CCC4=CC(=O)CCC34C)O)C)C(=O)CO
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Application site reaction12.07.01.006; 08.02.01.006--Not Available
Atrophy08.03.04.001--Not Available
Condition aggravated08.01.03.004--Not Available
Dermatitis23.03.04.002--Not Available
Dermatitis acneiform23.02.01.004--
Dermatitis contact23.03.04.004; 12.03.01.040; 10.01.01.003--Not Available
Dry skin23.03.03.001--
Eczema23.03.04.006--
Erythema23.03.06.001--Not Available
Folliculitis11.01.12.018; 23.09.04.007--
Fungal infection11.03.05.001--Not Available
Gastrointestinal disorder07.11.01.001--Not Available
Hypertrichosis23.02.04.002--
Infection11.01.08.002--Not Available
Irritability19.04.02.013; 08.01.03.011--
Leukoderma23.05.02.001--Not Available
Miliaria23.02.03.014--Not Available
Pain08.01.08.004--
Pruritus23.03.12.001--
Rash23.03.13.001--Not Available
Rash maculo-papular23.03.13.004--
Secondary adrenocortical insufficiency14.11.01.014; 05.01.02.003--Not Available
Skin atrophy23.01.05.001--
Skin hypopigmentation23.05.02.003--
Skin irritation23.03.04.009--Not Available
Skin striae23.01.05.002--Not Available
Telangiectasia24.03.03.003; 23.06.03.001--
Skin maceration23.03.03.016--Not Available
Growth retardation15.03.01.006--
Skin burning sensation23.03.03.021; 17.02.06.009--Not Available
The 1th Page    1 2    Next   Last    Total 2 Pages